Cross Loops Laminofab Private Limited

Textile trading and manufacturing of knitted, weaved, and laminated fabrics since 2014.

2014 | Delhi (India) | Active
Last Updated:

Cross Loops Laminofab Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 3.21 Cr
  • Revenue Growth 17.29%
  • Profit Growth 42.91%
  • Ebitda -6.72%
  • Net Worth 25.58%
  • Total Assets 26.29%

About Cross Loops Laminofab

Cross Loops Laminofab Private Limited (CLLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 February 2014 and has a history of 11 years and one month. Its registered office is in Delhi, India.

The Company is engaged in the Home & Lifestyle Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹3.21 Cr.

Ayush Bansal and Nikhil Tayal serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U17110DL2014PTC265502

  • Company No.

    265502

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    27 Feb 2014

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Home & Lifestyle

Who are the key members and board of directors at Cross Loops Laminofab?

Board Members (2)

NameDesignationAppointment DateStatus
Ayush Bansal Country flag representing In Director 27-Feb-2014Current
Nikhil Tayal Country flag representing In Director 27-Feb-2014Current

Financial Performance of Cross Loops Laminofab.

Cross Loops Laminofab Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.29% increase. The company also saw a substantial improvement in profitability, with a 42.91% increase in profit. The company's net worth Soared by an impressive increase of 25.58%.

Cross Loops Laminofab revenue growth over time
Cross Loops Laminofab profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
17.29%
Revenue from Operations
17.30%
Total Assets
26.29%
Profit or Loss
42.91%
Net Worth
25.58%
EBITDA
-6.72%

What is the Ownership and Shareholding Structure of Cross Loops Laminofab?

In 2020, Cross Loops Laminofab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹32.15 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 1.61 Cr
  • Yes Bank Limited : 1.60 Cr

Latest Charge Details

DateLenderAmountStatus
13 May 2024Yes Bank Limited₹1.60 CrOpen
27 Aug 2018Hdfc Bank Limited₹1.61 CrOpen

How Many Employees Work at Cross Loops Laminofab?

Unlock and access historical data on people associated with Cross Loops Laminofab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Cross Loops Laminofab Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cross Loops Laminofab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cross Loops Laminofab's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Cross Loops Laminofab

Recent activity within the organization

  • Charges

    A charge with Yes Bank Limited of Rs. 16.00 M registered on 13 May 2024 with Charge ID 100923334 was modified on 21 Nov 2024.

  • Annual General Meeting

    Cross Loops Laminofab Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Charges

    A charge with Yes Bank Limited amounted to Rs. 16.00 M with Charge ID 100923334 was registered on 13 May 2024.

  • Balance Sheet

    Cross Loops Laminofab Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 16.15 M registered on 27 Aug 2018 with Charge ID 100200127 was modified on 27 May 2022.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 16.15 M with Charge ID 100200127 was registered on 27 Aug 2018.

Frequently asked questions

  • What is the Incorporation or founding date of Cross Loops Laminofab Private Limited?

    Cross Loops Laminofab Private Limited was incorporated on 27 Feb 2014.

  • What is authorized share capital and paid-up capital of Cross Loops Laminofab Private Limited?

    The authorized share capital of Cross Loops Laminofab Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Cross Loops Laminofab Private Limited?

    Currently 2 directors are associated with Cross Loops Laminofab Private Limited.

    • Ayush Bansal
    • Nikhil Tayal

  • What is the registered address of Cross Loops Laminofab Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Cross Loops Laminofab Private Limited is House No 2/1 Onkar Nagar-B India, Tri Nagar, Delhi, 110035.

  • What is the corporate identification number (CIN) and company number of Cross Loops Laminofab Private Limited?

    The corporate identification number (CIN) of Cross Loops Laminofab Private Limited is U17110DL2014PTC265502 and the company number is 265502 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Cross Loops Laminofab Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Cross Loops Laminofab Private Limited has risen by 17.29%.

  • What change has been observed in the net worth of Cross Loops Laminofab Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Cross Loops Laminofab Private Limited has experienced an upsurge of 25.58%.

  • What are the total open charges for Cross Loops Laminofab Private Limited?

    As per the financial statements for fiscal Year 2022, The total open charges for Cross Loops Laminofab Private Limited amount to ₹ 3.21 Cr.

  • When was the last Balance Sheet of Cross Loops Laminofab Private Limited filed with the ROC?

    The most recent Balance Sheet for Cross Loops Laminofab Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed